UPDATE: Goldman Sachs Upgrades Horizon Therapeutics (HZNP) to Buy
Tweet Send to a Friend
(Updated - November 18, 2021 5:16 PM EST)
Goldman Sachs analyst Madhu Kumar upgraded Horizon Therapeutics (NASDAQ: HZNP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Madhu Kumar upgraded Horizon Therapeutics (NASDAQ: HZNP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
